Nothing Special   »   [go: up one dir, main page]

WO2007123686A3 - Dpp inhibitors and uses thereof - Google Patents

Dpp inhibitors and uses thereof Download PDF

Info

Publication number
WO2007123686A3
WO2007123686A3 PCT/US2007/007918 US2007007918W WO2007123686A3 WO 2007123686 A3 WO2007123686 A3 WO 2007123686A3 US 2007007918 W US2007007918 W US 2007007918W WO 2007123686 A3 WO2007123686 A3 WO 2007123686A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
dpp inhibitors
amino boronic
dpp
inhibitors
Prior art date
Application number
PCT/US2007/007918
Other languages
French (fr)
Other versions
WO2007123686A2 (en
Inventor
Paul A Mclean
Michael I Jesson
Glenn T Miller
Barry Jones
Geoffrey Alan Cole
Original Assignee
Point Therapeutics Inc
Paul A Mclean
Michael I Jesson
Glenn T Miller
Barry Jones
Geoffrey Alan Cole
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Point Therapeutics Inc, Paul A Mclean, Michael I Jesson, Glenn T Miller, Barry Jones, Geoffrey Alan Cole filed Critical Point Therapeutics Inc
Publication of WO2007123686A2 publication Critical patent/WO2007123686A2/en
Publication of WO2007123686A3 publication Critical patent/WO2007123686A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention provides, in part, amino boronic dipeptide agents, compositions thereof and methods of using the amino boronic dipeptide compositions in the treatment of disorders characterized by abnormal cell proliferation, cardiovascular disorders, and infectious diseases.
PCT/US2007/007918 2006-03-31 2007-03-30 Dpp inhibitors and uses thereof WO2007123686A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US78782006P 2006-03-31 2006-03-31
US60/787,820 2006-03-31
US85971606P 2006-11-17 2006-11-17
US60/859,716 2006-11-17

Publications (2)

Publication Number Publication Date
WO2007123686A2 WO2007123686A2 (en) 2007-11-01
WO2007123686A3 true WO2007123686A3 (en) 2008-07-03

Family

ID=38625467

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/007918 WO2007123686A2 (en) 2006-03-31 2007-03-30 Dpp inhibitors and uses thereof

Country Status (1)

Country Link
WO (1) WO2007123686A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106075450A (en) 2011-11-22 2016-11-09 塔夫茨大学信托人 Little molecule reinforcing agent for dendritic cell cancer vaccine
WO2018049027A1 (en) 2016-09-07 2018-03-15 Trustees Of Tufts College Combination therapies using immuno-dash inhibitors and pge2 antagonists
CN108864250A (en) * 2018-05-29 2018-11-23 北京大学 A kind of gemcitabine pro-drug and its preparation method and application of FAP α enzyme sensitivity
US20240252466A1 (en) * 2022-12-22 2024-08-01 Merck Sharp & Dohme Llc Cyclohexylgycine derivatives as selective cytotoxic agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911467B2 (en) * 1999-11-30 2005-06-28 Ferring Bv Antidiabetic agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911467B2 (en) * 1999-11-30 2005-06-28 Ferring Bv Antidiabetic agents

Also Published As

Publication number Publication date
WO2007123686A2 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
NL301145I1 (en)
WO2006003388A3 (en) Compositions and methods for treating inflammatory disorders
WO2009082701A8 (en) Hcv protease inhibitors and uses thereof
MX2010006736A (en) Hcv protease inhibitors and uses thereof.
WO2006124748A3 (en) Multicyclic compounds and methods of their use
LT1854477T (en) Peptides inhibiting plasma kallikrein for use in the treatment of ophthalmic disorders.
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2007075439A3 (en) Compositions and methods for treating obesity and related metabolic disorders
WO2011048390A3 (en) Gadd45beta targeting agents
WO2007106537A3 (en) Aminoquinolones as gsk-3 inhibitors
WO2007145704A3 (en) Gemcitabine combination therapy
WO2007073553A3 (en) Block copolymer particles
JO3358B1 (en) Ocular Allergy Treatments
WO2007016674A3 (en) 2-aminoaryl pyridines as protein kinases inhibitors
WO2009071689A3 (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
WO2009035634A3 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
WO2009114461A3 (en) Angiotensin (1-7) dosage forms and uses thereof
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis
EP1773363A4 (en) Ngna compositions and methods of use
TW200716561A (en) P38 inhibitors and methods of use thereof
WO2007103468A3 (en) Use of vx-702 for treating rheumatoid arthritis
WO2007123686A3 (en) Dpp inhibitors and uses thereof
AU2006278227A8 (en) Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules
WO2006136454A3 (en) Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07754437

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC DATED 23.01.2009.

122 Ep: pct application non-entry in european phase

Ref document number: 07754437

Country of ref document: EP

Kind code of ref document: A2